Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of a mid-stage trial with high rates of side effects such as nausea and vomiting. While Pfizer will now focus on a… Read Full Article (External Site) Dr. David LowemannDr. David […]

Consumers shouldn’t eat pre-cut cantaloupe if they don’t know the source, U.S. health officials said Thursday, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows. At least 117 people in 34 U.S. states have been sickened by contaminated… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]